Chronic myeloid leukemia: In pursuit of perfection.

about

Chronic myeloid leukemia: In pursuit of perfection.

Item

http://www.wikidata.org/entity/Q38181149

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chronic myeloid leukemia: In pursuit of perfection.

@en

type

Item

label

Chronic myeloid leukemia: In pursuit of perfection.

@en

prefLabel

Chronic myeloid leukemia: In pursuit of perfection.

@en

P1476

Chronic myeloid leukemia: In pursuit of perfection.

@en

P2093

Vishal Jayakar

http://www.w3.org/2001/XMLSchema#string

P2860

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.

Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase.

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.

P304

16-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2278-330X.96498

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24455503

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

3876599

http://www.w3.org/2001/XMLSchema#string